{"organizations": [], "uuid": "314ea0f3f0a78f29c7225c96709fef3a942fd251", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fusion-antibodies-says-at-least-40/brief-fusion-antibodies-says-at-least-40-pct-revenue-growth-expected-in-fy-idUSFWN1QN03K", "country": "US", "domain_rank": 408, "title": "BRIEF-Fusion Antibodies Says At Least 40 Pct Revenue Growth Expected​ in FY", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.934, "site_type": "news", "published": "2018-03-05T15:25:00.000+02:00", "replies_count": 0, "uuid": "314ea0f3f0a78f29c7225c96709fef3a942fd251"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fusion-antibodies-says-at-least-40/brief-fusion-antibodies-says-at-least-40-pct-revenue-growth-expected-in-fy-idUSFWN1QN03K", "ord_in_thread": 0, "title": "BRIEF-Fusion Antibodies Says At Least 40 Pct Revenue Growth Expected​ in FY", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fusion antibodies plc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Fusion Antibodies Plc:\n* ‍FOR YEAR ENDING 31 MARCH 2018 AT LEAST 40% REVENUE GROWTH EXPECTED​\n* ‍REVENUE FOR FULL YEAR 2017/18 IS BEHIND MARKET EXPECTATIONS​\n* ‍CONTINUE TO HAVE POSITIVE OUTLOOK FOR 2018/19 IN LINE WITH EXPECTATIONS.​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T15:25:00.000+02:00", "crawled": "2018-03-06T22:35:56.000+02:00", "highlightTitle": ""}